VENKATESWARLU MUVVA: Open Payments
NPI 1942480553 · LUTZ, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 23 payments from 9 companies in 2025. Trend: 2023 $107 · 2024 $87 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 7 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $133 |
| ABBVIE INC. | 3 | $56 |
| Exact Sciences Corporation | 2 | $39 |
| Braeburn Inc. | 1 | $25 |
| Itamar Medical Inc | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
| Atland Pharmaceuticals, LLC | 1 | $15 |
Products named: SUBLOCADE, CAPLYTA, VRAYLAR, BRIXADI, The Cologuard Plus Collection Kit, WatchPATONE, RELISTOR, Ozempic.
Industry payments across FL — which companies pay providers there.
